Circulation Research, Vol 62, 1055-1058, Copyright © 1988 by American Heart Association

ARTICLES

Quinidine delays IK activation in guinea pig ventricular myocytes

DM Roden, PB Bennett, DJ Snyders, JR Balser and LM Hondeghem
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

A major action of the antiarrhythmic agent quinidine is prolongation of cardiac repolarization. In these experiments, the time-dependent effects of quinidine on the delayed rectifier potassium current, IK, a current contributing to cardiac repolarization, were investigated in acutely disaggregated guinea pig ventricular myocytes using the whole- cell recording configuration of the patch-clamp method. The effect of quinidine on IK was dependent on the duration of depolarization. After long (2,000 msec) pulses, IK was reduced by 30 +/- 27% (SD; n = 8, paired) by 10 microM quinidine; in contrast, after short (100 msec) pulses, the drug decreased IK 65 +/- 35% (p less than 0.05). This effect was found both in paired experiments as well as when quinidine- pretreated cells were compared to non-pretreated cells. Quinidine significantly delayed IK activation (9 +/- 20 msec at baseline vs. 44 +/- 25 msec in drug, p less than 0.05), but did not alter the subsequent time course of activation (time constant 659 +/- 118 msec). These findings are consistent with the hypothesis that quinidine promotes occupancy of a channel state from which opening does not occur.

This article has been cited by other articles:

				K. Aoki, K. Kosakai, and M. Yoshino Monoaminergic Modulation of the Na+-Activated K+ Channel in Kenyon Cells Isolated From the Mushroom Body of the Cricket (Gryllus bimaculatus) Brain J Neurophysiol, September 1, 2008; 100(3): 1211 - 1222. [Abstract] [Full Text] [PDF]

				Y. Blaauw, U. Schotten, A. van Hunnik, H.R. Neuberger, and M.A. Allessie Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat Cardiovasc Res, July 1, 2007; 75(1): 89 - 98. [Abstract] [Full Text] [PDF]

				C. Van Mieghem, M. Sabbe, and D. Knockaert The Clinical Value of the ECG in Noncardiac Conditions Chest, April 1, 2004; 125(4): 1561 - 1576. [Abstract] [Full Text] [PDF]

				R. L. Hamlin, A. Kijtawornrat, B. W. Keene, and D. M. Hamlin QT and RR Intervals in Conscious and Anesthetized Guinea Pigs with Highly Varying RR Intervals and Given QTc-Lengthening Test Articles Toxicol. Sci., December 1, 2003; 76(2): 437 - 442. [Abstract] [Full Text] [PDF]

				N. lost, L. Virag, A. Varro, and J. Gy. Papp Comparison of the Effect of Class IA Antiarrhythmic Drugs on Transmembrane Potassium Currents in Rabbit Ventricular Myocytes Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1): 31 - 41. [Abstract] [PDF]

				J C Hancox, K C R Patel, and J V Jones Antiarrhythmics---from cell to clinic: past, present, and future Heart, July 1, 2000; 84(1): 14 - 24. [Full Text] [PDF]

				B. Drolet, A. Emond, B. Pharm, V. Fortin, P. Daleau, G. Rousseau, R. Cardinal, and J. Turgeon Vitamin K Modulates Cardiac Action Potential by Blocking Sodium and Potassium Ion Channels Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 267 - 273. [Abstract] [PDF]

				H. Zhang, B. Zhu, J.-A. Yao, and G.-N. Tseng Differential Effects of S6 Mutations on Binding of Quinidine and 4-Aminopyridine to Rat Isoform of Kv1.4: Common Site but Different Factors in Determining Blockers' Binding Affinity J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 332 - 343. [Abstract] [Full Text]

				L. Eckardt, W. Haverkamp, M. Borggrefe, and G. Breithardt Experimental models of torsade de pointes Cardiovasc Res, July 1, 1998; 39(1): 178 - 193. [Abstract] [Full Text] [PDF]

				E. A. Sosunov, E. P. Anyukhovsky, and M. R. Rosen Effects of Quinidine on Repolarization in Canine Epicardium, Midmyocardium, and Endocardium : I. In Vitro Study Circulation, December 2, 1997; 96(11): 4011 - 4018. [Abstract] [Full Text]

				G. Stark, I. Schwarzl, U. Heiden, U. Stark, and H. A Tritthart Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol Cardiovasc Res, July 1, 1997; 35(1): 43 - 51. [Abstract] [Full Text] [PDF]

				E. Patterson, B. J. Scherlag, S. Sangiah, G. L. Garrison, K. M. Couch, K. D. Berlin, and R. Lazzara Class III Electrophysiologic Actions of Imidazole-Substituted Diheterabicyclononanes in Canine Myocardium J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 155 - 162. [Abstract] [Full Text]

				M. Nemeth, A. Varro, L. Virag, O. Hala, D. Thormahlen, and J. Gyula Papp Frequency-dependent Cardiac Electrophysiologic Effects of Tedisamil: Comparison With Quinidine and Sotalol Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 273 - 284. [Abstract] [PDF]

				P. Smits, S. B. Williams, D. E. Lipson, P. Banitt, G. A. Rongen, and M. A. Creager Endothelial Release of Nitric Oxide Contributes to the Vasodilator Effect of Adenosine in Humans Circulation, October 15, 1995; 92(8): 2135 - 2141. [Abstract] [Full Text]

				H. J. Duff, Z.-P. Feng, and R. S. Sheldon High- and Low-Affinity Sites for [3H]Dofetilide Binding to Guinea Pig Myocytes Circ. Res., October 1, 1995; 77(4): 718 - 725. [Abstract] [Full Text]

				D.-W. Liu and C. Antzelevitch Characteristics of the Delayed Rectifier Current (IKr and IKs) in Canine Ventricular Epicardial, Midmyocardial, and Endocardial Myocytes : A Weaker IKs Contributes to the Longer Action Potential of the M Cell Circ. Res., March 1, 1995; 76(3): 351 - 365. [Abstract] [Full Text]